microdose retatrutide Retatrutide: The triple-action peptide revolutionizing weight loss Retatrutide vs tirzepatide for weight
Description
Merck had other China deals in the last few months (LaNova Medicines and Curon Biopharmaceutical), but all deals are either early-stage (ongoing Phase 1) or pre-clinical (Hansoh)
The preliminary data on the effect of GLP-1 RAson asthma in patients with diabetes are promising and merit further trials and research studies.
doi:10.2337/dc22-1148 #GLP1 #Diabetes #ThyroidCancer #Pharmacovigilance #MedicalEducation
On December 23, 2024, the FDA approved the first generic Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor agonist.
